Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway
Open accessAbstract
The Japanese mugwort, Artemisia princeps (yomogi in Japanese), has anti-inflammatory and antioxidant effects. Skin care products containing Artemisia princeps extract (APE) are known to improve dry skin symptoms in atopic dermatitis. Atopic dry skin is associated with a marked reduction of skin barrier proteins, such as filaggrin (FLG) and loricrin (LOR). Recently, aryl hydrocarbon receptor (AHR), and its downstream transcription factor OVO-like 1 (OVOL1), have been shown to regulate the gene expression of FLG and LOR. The focus of this paper is to evaluate the effects of APE on the AHR/OVOL1/FLG or LOR pathway since they have remained unknown to this point. We first demonstrated that non-cytotoxic concentrations of APE significantly upregulated antioxidant enzymes, NAD(P)H dehydrogenase quinone 1 and heme oxygenase 1, in human keratinocytes. Even at these low concentrations, APE induced nuclear translocation of AHR and significantly upregulated CYP1A1 (a specific target gene for AHR activation), FLG, and LOR expression. AHR knockdown downregulated OVOL1 expression. The APE-induced upregulation of FLG and LOR was canceled in keratinocytes with AHR or OVOL1 knockdown. In conclusion, antioxidant APE is a potent phytoextract that upregulates FLG and LOR expression in an AHR/OVOL1-dependent manner and this may underpin the barrier-repairing effects of APE in treating atopic dry skin.
AI snapshot
Written from the paper’s full text.
TL;DR
Antioxidant Artemisia princeps extract (APE) activates NRF2/NQO1·HO1 and AHR signaling in normal human epidermal keratinocytes. APE upregulates filaggrin (FLG) and loricrin (LOR) via an AHR/OVOL1-dependent pathway.
Key findings
- Non-cytotoxic APE concentrations (≤0.03%) induced nuclear translocation of NRF2 and significantly upregulated antioxidant enzymes NQO1 and HO1 in NHEKs; APE >0.3% decreased cell viability.
- APE induced AHR nuclear translocation and dose-dependent CYP1A1 upregulation; AHR siRNA transfection (91.9 ± 2.1% inhibition of AHR mRNA) canceled APE-induced CYP1A1 upregulation.
- APE upregulated FLG and LOR gene expression in dose- and time-dependent manners; this upregulation was canceled by AHR knockdown or OVOL1 knockdown (OVOL1 siRNA inhibition efficiency 71.5 ± 2.4%).
- APE-induced NQO1 expression was only minimally downregulated and HO1 expression was rather enhanced in AHR-knockdown NHEKs, suggesting an AHR-independent pathway mainly operates for APE-mediated NRF2/NQO1·HO1 signaling.
Methods
- Normal human epidermal keratinocytes (NHEKs) were cultured and treated with APE (0.01% or 0.03% for gene expression; up to 1% for cytotoxicity). Cytotoxicity was assessed by WST-1 assay after 24 h.
- Real-time PCR measured CYP1A1, FLG, LOR, OVOL1, NQO1, and HO1 with β-actin (ACTB) as housekeeping gene; immunofluorescence assessed AHR and NRF2 nuclear translocation.
- siRNA transfection against AHR, OVOL1, or control was used, followed by 0.03% APE for 24 h; statistical analysis used unpaired Student’s t test with p < 0.05.
Limitations
- The paper does not explicitly state limitations.
- Evident from the text: all experiments were performed in cultured NHEKs in vitro, with no animal model or clinical validation.
- Evident from the text: APE is a complex water extract with unidentified active constituents, and the AHR-independent NRF2/NQO1·HO1 pathway is inferred from knockdown results but not fully dissected.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
27 of 55 cited sources checked · 16 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Upregulation of Flg is correlated with efficient barrier recovery of tape-stripped barrier-disrupted murine skin.
“upregulation of Flg is correlated with efficient barrier recovery of tape-stripped barrier-disrupted murine skin [32,33]”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [32] Hou, 2012, Topical hesperidin improves epidermal permeability barrier function and epidermal differentiation in normal murine skin, Exp. Dermatol. source
- cites [33] Hou, 2013, Topical apigenin improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms, Exp. Dermatol. source
- Study design and conductcitation
β-actin (ACTB) was used as a control housekeeping gene because its gene expression is not affected by AHR ligation.
“We used β-actin (ACTB) as a control housekeeping gene, because its gene expression is not affected by AHR ligation [18,35].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [18] Tsuji, 2017, Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis, Cell Death Dis. source
The Materials and Methods section (Quantitative reverse transcription-PCR analysis; page not provided) says mRNA levels were normalized to β-actin, supporting its use as a control gene. The paper does not state or demonstrate that ACTB gene expression is unaffected by AHR ligation; that reason for choosing it is not supported. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [35] Frauenstein, 2013, Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1, Cell Death Differ. source
The Quantitative real-time PCR subsection of Materials and Methods (page unavailable) says gene expression was normalized to β-actin, supporting its use as a control. Our copy does not state or demonstrate that β-actin expression is unaffected by AHR ligation; the reported lack of response to an AHR agonist concerns E2F1 promoter activity, not β-actin. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Perturbed barrier function is critical for the development of atopic dermatitis and other allergic disorders, namely atopic march.
“Perturbed barrier function is critical for the development of not only atopic dermatitis but also other allergic disorders, namely, atopic march [8,9,10,11].”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [8] Elias, 2014, Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in atopic dermatitis, J. Allergy Clin. Immunol. source
- cites [9] Kubo, 2012, Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases, J. Clin. Investig. source
- cites [10] Palmer, 2006, Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis, Nat. Genet. source
- cites [11] Park, 2015, Novel FLG null mutations in Korean patients with atopic dermatitis and comparison of the mutational spectra in Asian populations, J. Dermatol. source
- Premisecitation
FLG and LOR expression levels are reduced in lesional and non-lesional skin in atopic dermatitis.
“Atopic dry skin is associated with a marked reduction of skin barrier proteins, such as filaggrin (FLG) and loricrin (LOR).”
- Also stated in: § 1. Introduction · plain
“FLG and LOR expression levels have been reported to be reduced in lesional and non-lesional skin in atopic dermatitis [12,13].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [12] Jensen, 2004, Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis, J. Investig. Dermatol. source
The Results (Figure 3; page unavailable) report significantly reduced filaggrin staining in both non-lesional and lesional atopic skin. But the Results (Figure 4; page unavailable) report increased, not reduced, loricrin levels in both. Thus the claim is supported for FLG but contradicted for LOR. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [13] Bergboer, 2013, Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis, J. Clin. Investig.
Not checked in the free run.
- Also stated in: § 1. Introduction · plain
- Premisecitation
AHR is an essential transcription factor for human epidermal barrier proteins including FLG and LOR.
“In addition to CYP1A1 induction, AHR is an essential transcription factor for human epidermal barrier proteins including FLG and LOR [17,28,29].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [17] Furue, 2015, Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor, J. Dermatol. Sci. source
- cites [28] Sutter, 2011, 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation, Toxicol. Sci. source
The Results (page unavailable) show that AHR activation increases transcription of human FLG. But the Discussion (page unavailable) explicitly says AHR is not essential for epidermal barrier formation, and the passages found do not establish that it is essential for FLG or LOR expression. A search for LOR/loricrin found no supporting passage. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [29] Kennedy, 2013, 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation, Toxicol. Sci. source
The introductory passage under Abstract reports that TCDD-activated AHR binds the FLG promoter and directly regulates FLG transcription. The Results section, “TCDD Increases the Expression of Genes Required for Cornified Envelope Formation,” reports increased FLG expression, but the paper identifies LOR (loricrin) as a barrier protein without establishing that AHR regulates it or is essential for expression of either protein under normal conditions. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data
APE-induced LOR upregulation is significantly inhibited in NHEKs with AHR knockdown.
“APE upregulated the FLG and LOR gene expression in NHEKs transfected with control siRNA, but the enhancing effect was significantly inhibited in NHEKs with AHR knockdown due to transfection with AHR siRNA (Figure 4A,B).”
Quote in the paperSubstantial claim - Findingown data
APE-induced LOR upregulation is canceled in NHEKs with OVOL1 knockdown.
“Moreover, APE-induced upregulation of FLG and LOR gene expression was canceled in NHEKs with OVOL1 knockdown compared with that in NHEKs transfected with control siRNA (Figure 4C,D).”
Quote in the paperSubstantial claim - Findingown data
APE-induced FLG upregulation is significantly inhibited in NHEKs with AHR knockdown.
“APE upregulated the FLG and LOR gene expression in NHEKs transfected with control siRNA, but the enhancing effect was significantly inhibited in NHEKs with AHR knockdown due to transfection with AHR siRNA (Figure 4A,B).”
Quote in the paperSubstantial claim - Findingown data
APE-induced HO1 expression is rather enhanced in AHR-knockdown NHEKs.
“Moreover, APE-induced HO1 expression was rather enhanced in AHR-knockdown NHEKs.”
Quote in the paperSubstantial claim - Findingown data
APE induces nuclear translocation of NRF2 in NHEKs.
“In control NHEKs, NRF2 was present mainly in the cytoplasm, whereas nuclear staining became enhanced in the presence of APE (Figure 1A).”
- Also stated in: § 2.1. APE Upregulated Antioxidant NRF2/NQO1 Pathway in Normal Human Epidermal Keratinocytes · plain
“The number of NHEKs with nuclear-predominant staining was significantly increased by APE treatment compared with control (Figure 1B).”
Quote in the paperNot a substantial claim - Also stated in: § 2.1. APE Upregulated Antioxidant NRF2/NQO1 Pathway in Normal Human Epidermal Keratinocytes · plain
- Findingown data
APE-induced NQO1 expression is only minimally downregulated in NHEKs transfected with AHR siRNA.
“As shown in Figure S4, APE-induced NQO1 expression was only minimally downregulated in NHEKs transfected with AHR siRNA.”
Quote in the paperSubstantial claim - Findingown data
APE upregulates LOR gene expression in NHEKs.
“As shown in Figure 3A,B, the levels of FLG and LOR gene expression were upregulated in the presence of APE.”
- Also stated in: § 2.3. APE Induced FLG and LOR Gene Upregulation in an AHR/OVOL1-Dependent Manner · plain
“APE upregulated the FLG and LOR gene expression in NHEKs transfected with control siRNA”
Quote in the paperSubstantial claim - Also stated in: § 2.3. APE Induced FLG and LOR Gene Upregulation in an AHR/OVOL1-Dependent Manner · plain
- Findingown data
APE significantly upregulated HO1 expression in NHEKs.
“APE significantly upregulated the NQO1 and HO1 expression (Figure 1C,D)”
- Also stated in: § 2.1. APE Upregulated Antioxidant NRF2/NQO1 Pathway in Normal Human Epidermal Keratinocytes · plain
“In parallel with the nuclear translocation of NRF2, APE significantly upregulated the NQO1 and HO1 expression (Figure 1C,D), showing that the low concentration of APE did possess an antioxidant property.”
Quote in the paperNot a substantial claim - Also stated in: § 2.1. APE Upregulated Antioxidant NRF2/NQO1 Pathway in Normal Human Epidermal Keratinocytes · plain
- Findingown data
APE induces nuclear translocation of AHR in NHEKs.
“AHR was mainly located in the cytoplasm in untreated control NHEKs (upper panel). However, nuclear staining of AHR is enhanced in the keratinocytes treated with APE (lower panel in Figure 2A).”
- Also stated in: § 2.2. APE-Induced AHR Activation in NHEKs · plain
“The number of NHEKs with nuclear-predominant staining of AHR was significantly increased by APE treatment than that of control (Figure 2B).”
Quote in the paperSubstantial claim - Also stated in: § 2.2. APE-Induced AHR Activation in NHEKs · plain
- Findingown data
APE-induced OVOL1 upregulation is AHR-dependent, as it is canceled in NHEKs transfected with AHR siRNA.
“The APE-induced OVOL1 upregulation was AHR-dependent because it was canceled in NHEKs transfected with AHR siRNA (Figure S3).”
Quote in the paperSubstantial claim - Findingown data
APE significantly upregulates CYP1A1 gene expression in a dose-dependent manner in NHEKs.
“As shown in Figure 2C, APE significantly upregulated CYP1A1 gene expression in a dose-dependent manner.”
Quote in the paperSubstantial claim - Findingown data
APE-induced FLG upregulation is canceled in NHEKs with OVOL1 knockdown.
“Moreover, APE-induced upregulation of FLG and LOR gene expression was canceled in NHEKs with OVOL1 knockdown compared with that in NHEKs transfected with control siRNA (Figure 4C,D).”
Quote in the paperSubstantial claim - Findingown data
APE upregulates FLG gene expression in NHEKs.
“As shown in Figure 3A,B, the levels of FLG and LOR gene expression were upregulated in the presence of APE.”
- Also stated in: § 2.3. APE Induced FLG and LOR Gene Upregulation in an AHR/OVOL1-Dependent Manner · plain
“APE upregulated the FLG and LOR gene expression in NHEKs transfected with control siRNA”
Quote in the paperSubstantial claim - Also stated in: § 2.3. APE Induced FLG and LOR Gene Upregulation in an AHR/OVOL1-Dependent Manner · plain
- Findingown data
APE at concentrations >0.3% decreased the cell viability of NHEKs.
“APE at concentrations >0.3% decreased the cell viability of NHEKs (Figure S2).”
Quote in the paperNot a substantial claim - Findingown data
APE increases FLG gene expression in a time-dependent manner.
“Time course assay revealed time-dependent increases in gene expression for both FLG and LOR (Figure 3C,D).”
Quote in the paperSubstantial claim - Findingown data
APE significantly upregulated NQO1 expression in normal human epidermal keratinocytes (NHEKs).
“APE significantly upregulated the NQO1 and HO1 expression (Figure 1C,D)”
- Also stated in: § 2.1. APE Upregulated Antioxidant NRF2/NQO1 Pathway in Normal Human Epidermal Keratinocytes · plain
“In parallel with the nuclear translocation of NRF2, APE significantly upregulated the NQO1 and HO1 expression (Figure 1C,D), showing that the low concentration of APE did possess an antioxidant property.”
Quote in the paperNot a substantial claim - Also stated in: § 2.1. APE Upregulated Antioxidant NRF2/NQO1 Pathway in Normal Human Epidermal Keratinocytes · plain
- Findingown data
APE-induced CYP1A1 upregulation is canceled in NHEKs transfected with AHR siRNA.
“The APE-induced CYP1A1 upregulation was canceled in the NHEKs transfected with AHR siRNA (Figure 2D).”
Quote in the paperSubstantial claim - Findingown data
APE upregulates OVOL1 expression in NHEKs.
“In addition, APE also upregulated OVOL1 expression (Figure S3).”
Quote in the paperSubstantial claim - Findingown data
APE increases LOR gene expression in a time-dependent manner.
“Time course assay revealed time-dependent increases in gene expression for both FLG and LOR (Figure 3C,D).”
Quote in the paperNot a substantial claim - Interpretationown data
An AHR-independent pathway is mainly operative in APE-mediated NRF2/NQO1·HO1 signaling.
“These results suggest that AHR-independent pathway is mainly operative in APE-mediated NRF2/NQO1·HO1 signaling.”
Quote in the paperSubstantial claim - Interpretationown data
APE-induced upregulation of FLG and LOR may underpin the barrier-repairing effects of APE in treating atopic dry skin.
“In conclusion, antioxidant APE is a potent phytoextract that upregulates FLG and LOR expression in an AHR/OVOL1-dependent manner and this may underpin the barrier-repairing effects of APE in treating atopic dry skin.”
Quote in the paperSubstantial claim- Rests on an assumption: Upregulation of FLG and LOR gene expression by APE in cultured NHEKs is sufficient to produce barrier-repairing effects in atopic dry skin.
- Interpretationown data
APE activates NRF2/NQO1·HO1 signaling, which mediates its antioxidant property.
“In this study, we showed that antioxidant APE activates NRF2/NQO1·HO1 pathway and upregulates the expression of FLG and LOR in an AHR/OVOL1-dependent manner.”
- Also stated in: § 3. Discussion · boosted
“In order to understand APE’s molecular mechanisms better, we first revealed the antioxidant property of non-cytotoxic concentrations of APE by demonstrating its action on NRF2/NQO1 and HO1 signaling.”
Quote in the paperSubstantial claim - Also stated in: § 3. Discussion · boosted
- Study design and conductown data
The inhibitory efficiency of OVOL1 siRNA transfection for OVOL1 mRNA expression was 71.5 ± 2.4% in NHEKs.
“The inhibitory efficiency of OVOL1 siRNA transfection for OVOL1 mRNA expression was 71.5 ± 2.4% in NHEKs.”
Quote in the paperSubstantial claim - Interpretationown data
APE upregulates FLG and LOR expression via the AHR/OVOL1 axis.
“These results indicate that APE enhanced FLG and LOR gene expression via the AHR/OVOL1 axis.”
- Also stated in: § Abstract · plain
“In conclusion, antioxidant APE is a potent phytoextract that upregulates FLG and LOR expression in an AHR/OVOL1-dependent manner and this may underpin the barrier-repairing effects of APE in treating atopic dry skin.”
- Also stated in: § 1. Introduction · boosted
“In this study, we showed that antioxidant APE activates NRF2/NQO1·HO1 pathway and upregulates the expression of FLG and LOR in an AHR/OVOL1-dependent manner.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Classified as probably not a substantial claim. 15
- May combine two claims. 12
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTopical agent with AHR agonistic activity is beneficial for atopic dermatitis in clinical trial.
“Recently, topical agent with AHR agonistic activity has been reported to be beneficial for atopic dermatitis in clinical trial [36,37].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [36] Bissonnette, 2012, Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: Results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial, Br. J. Dermatol. source
- cites [37] Smith, S.H., Jayawickreme, C., Rickard, D.J., Nicodeme, E., Bui, T., Simmons, C., Coquery, C.M., Neil, J., Pryor, W.M., and Mayhew, D. (2017). Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans. J. Investig. Dermatol. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationArtemisia princeps extract (APE) has anti-inflammatory and antioxidant effects.
“The Japanese mugwort, Artemisia princeps (yomogi in Japanese), has anti-inflammatory and antioxidant effects.”
- Also stated in: § 1. Introduction · boosted
“Many studies have demonstrated the anti-atherosclerotic, anti-oxidant, and anti-inflammatory effects of Artemisia princeps extract [1,2,3].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [1] Chung, 2015, Chemopreventive effects of standardized ethanol extract from the aerial parts of Artemisia princeps Pampanini cv. Sajabal via NF-κB inactivation on colitis-associated colon tumorigenesis in mice, Food Chem. Toxicol. source
- cites [2] Yamamoto, 2011, Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet, Food Func. source
- cites [3] Choi, 2013, Antioxidant and anticancer activity of Artemisia princeps var. orientalis extract in HepG2 and Hep3B hepatocellular carcinoma cells, Chin. J. Cancer Res. source
The Discussion reports significant antioxidant activity of Artemisia princeps var. orientalis methanol extract in hepatocarcinoma cell lines. It does not report an anti-inflammatory effect, so the source supports only the antioxidant part of the claim. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Also stated in: § 1. Introduction · boosted
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe NRF2/NQO1 and HO1 axis is essentially involved in antioxidant activity in keratinocytes.
“The NRF2/NQO1 and HO1 axis is essentially involved in antioxidant activity in keratinocytes [19].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [19] Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., and Tsuji, G. (2017). Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2. Nutrients, 9. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome ligands for AHR, such as coal tar and soybean tar, actively upregulate FLG and LOR expression.
“Some ligands for AHR, such as coal tar and soybean tar, actively upregulate FLG and LOR expression [13,14].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [13] Bergboer, 2013, Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis, J. Clin. Investig.
Not checked in the free run.
- cites [14] Takei, 2015, Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor, J. Dermatol. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe ligand/AHR complex binds to specific DNA recognition sites and upregulates transcription of responsive genes, such as CYP1A1, leading to robust generation of reactive oxygen species.
“The ligand/AHR complex then binds to specific DNA recognition sites, namely, xenobiotic-responsive elements or dioxin-responsive elements, and upregulates the transcription of a series of responsive genes, such as CYP1A1 leading to a robust generation of reactive oxygen species [16,24].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [16] Furue, 2014, Role of AhR/ARNT system in skin homeostasis, Arch. Dermatol. Res. source
The AhR/ARNT signaling section says the ligand–AhR–ARNT complex binds xenobiotic- or dioxin-responsive elements and induces CYP1A1; its Fig. 1 caption says CYP1A1 metabolism of ligands such as dioxins produces many reactive oxygen species. But the oxidative-stress section says ROS production is ligand-dependent and that some AhR ligands activate the pathway without producing ROS. The claim overgeneralizes that outcome. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [24] Ikuta, 2009, AhR protein trafficking and function in the skin, Biochem. Pharmacol. source
May combine two claims.
PremisecitationLigation of AHR activates OVOL1, which induces FLG and LOR expression.
“A recent study has also clarified that the ligation of AHR activates the downstream transcription factor OVO-like 1 (OVOL1), which then induces FLG and LOR expression [18].”
- Also stated in: § 3. Discussion · boosted
“Our recent study demonstrated that OVOL1 is engaged in the AHR-mediated upregulation of FLG and LOR [18].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] Tsuji, 2017, Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis, Cell Death Dis. source
- Also stated in: § 3. Discussion · boosted
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVarious external and internal ligands, such as dioxins, polycyclic aromatic pollutants, benzo[a]pyrene, and phytochemicals, can bind to and activate AHR.
“Various external and internal ligands, such as dioxins, polycyclic aromatic pollutants, benzo[a]pyrene, and phytochemicals, can bind to and activate AHR [15,16].”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther antioxidant phytochemicals such as cinnamaldehyde activate NRF2 without activating AHR.
“Other antioxidant phytochemicals such as cinnamaldehyde activate NRF2 without activating AHR [19,22].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [19] Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., and Tsuji, G. (2017). Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2. Nutrients, 9. source
- cites [22] Uchi, 2017, Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes, J. Dermatol. Sci. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome antioxidant phytochemicals such as soybean tar and Opuntia ficus-indica extract activate NRF2 via the AHR pathway.
“Some antioxidant phytochemicals such as soybean tar and Opuntia ficus-indica extract activate NRF2 via AHR pathway [14,19,21].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [14] Takei, 2015, Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor, J. Dermatol. source
- cites [19] Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., and Tsuji, G. (2017). Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2. Nutrients, 9. source
- cites [21] Nakahara, 2015, Antioxidant Opuntia ficus-indica extract activates AHR-NRF2 signaling and upregulates filaggrin and loricrin expression in human keratinocytes, J. Med. Food source
May combine two claims.
PremisecitationBoth coal tar and soybean tar actively enhance the expression of FLG and LOR via AHR.
“As both remedies actively enhance the expression of FLG and LOR via aryl hydrocarbon receptor (AHR) [13,14], the AHR-mediated upregulation of barrier proteins has attracted increasing attention in skin barrier and inflammation research [15,16,17].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [13] Bergboer, 2013, Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis, J. Clin. Investig.
Not checked in the free run.
- cites [14] Takei, 2015, Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor, J. Dermatol. source
The Introduction reports that coal tar activates AhR and upregulates filaggrin and loricrin. The Results show that soybean tar Glyteer activates AhR, upregulates both genes, and requires AhR for its effect on filaggrin; they do not establish that its loricrin upregulation requires AhR. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAHR-targeting antioxidant phytochemicals or antioxidant medicinal chemicals do not generate appreciable amounts of reactive oxygen species, probably due to efficient induction of antioxidant enzymes mediated by NRF2 activation.
“Notably, the AHR-targeting antioxidant phytochemicals or antioxidant medicinal chemicals do not generate appreciable amounts of reactive oxygen species probably due to efficient induction of antioxidant enzymes mediated by NRF2 activation [19,20,21,27].”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [19] Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., and Tsuji, G. (2017). Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2. Nutrients, 9. source
Section 2 (page not available) says that ketoconazole activates AHR without producing ROS and that antioxidant phytochemicals can activate AHR–NRF2 signaling without appreciable ROS production. The Introduction and Conclusions say NRF2 induces antioxidant enzymes, but the paper does not establish that this induction explains the lack of ROS production; it says the mechanisms remain largely unknown. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [20] Tsuji, 2012, Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: The basis of its anti-inflammatory effect, J. Investig. Dermatol. source
- cites [21] Nakahara, 2015, Antioxidant Opuntia ficus-indica extract activates AHR-NRF2 signaling and upregulates filaggrin and loricrin expression in human keratinocytes, J. Med. Food source
- cites [27] Takei, 2015, Galactomyces fermentation filtrate prevents T helper 2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner, Clin. Exp. Dermatol. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAntioxidant phytochemicals activate and induce cytoplasmic-to-nuclear translocation of NRF2, a master transcription factor for gene expression of antioxidant enzymes such as NQO1 and HO1 in keratinocytes.
“In general, antioxidant phytochemicals activate and induce the cytoplasmic-to-nuclear translocation of nuclear factor-erythroid 2-related factor-2 (NRF2), which is a master transcription factor for gene expression of antioxidant enzymes such as NAD(P)H dehydrogenase quinone 1 (NQO1) and heme oxygenase 1 (HO1) in keratinocytes [19,20].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [19] Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., and Tsuji, G. (2017). Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2. Nutrients, 9. source
- cites [20] Tsuji, 2012, Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: The basis of its anti-inflammatory effect, J. Investig. Dermatol. source
May combine two claims.
PremisecitationSkin inflammation decreases FLG and LOR expression and disrupts epidermal barrier function; barrier dysfunction augments skin inflammation.
“Skin inflammation decreases FLG and LOR expression and disrupts epidermal barrier function; moreover, in the opposite direction, barrier dysfunction augments skin inflammation [12,13,26].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [12] Jensen, 2004, Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis, J. Investig. Dermatol. source
The Discussion reports reduced filaggrin in atopic skin, and the passage labeled Abstract describes barrier disruption promoting eczematous dermatitis. But the Results and Discussion report increased—not decreased—loricrin in both lesional and non-lesional atopic skin. The paper also does not establish that inflammation caused the observed expression changes. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [13] Bergboer, 2013, Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis, J. Clin. Investig.
Not checked in the free run.
- cites [26] Egawa, 2016, Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march, J. Allergy Clin. Immunol. source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationAHR is a xenobiotic chemical sensor expressed abundantly in epidermal keratinocytes.
“AHR is a xenobiotic chemical sensor that is expressed abundantly in epidermal keratinocytes [15,16].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [15] Esser, 2013, Functions of the aryl hydrocarbon receptor in the skin, Semin. Immunopathol. source
- cites [16] Furue, 2014, Role of AhR/ARNT system in skin homeostasis, Arch. Dermatol. Res. source
The Introduction describes AhR as a receptor for exogenous chemicals and says keratinocytes possess it; the AhR/ARNT signaling section links it to responses to xenobiotics. Neither passage establishes that AhR is expressed abundantly in epidermal keratinocytes. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVarious herbal and antioxidant phytochemicals activate AHR.
“Various herbal and antioxidant phytochemicals have been shown to activate AHR [16,17,19].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [16] Furue, 2014, Role of AhR/ARNT system in skin homeostasis, Arch. Dermatol. Res. source
- cites [17] Furue, 2015, Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor, J. Dermatol. Sci. source
- cites [19] Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., and Tsuji, G. (2017). Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2. Nutrients, 9. source
May combine two claims.
Study design and conductown dataThe siRNA transfection did not affect cell viability and the inhibitory efficiency of AHR siRNA transfection for AHR mRNA expression was 91.9 ± 2.1%.
“The siRNA transfection did not affect cell viability and the inhibitory efficiency of AHR siRNA transfection for AHR mRNA expression was 91.9 ± 2.1%.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationSkin barrier maturation is accomplished by sequential and coordinated expression of various skin barrier proteins, such as FLG and LOR.
“Skin barrier maturation is accomplished by sequential and coordinated expression of various skin barrier proteins, such as filaggrin (FLG) and loricrin (LOR) [7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Proksch, 2008, The skin: An indispensable barrier, Exp. Dermatol. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFlg-deficient mice exhibit reduced epidermal barrier function with enhanced susceptibility to environmental sensitization.
“Flg-deficient mice exhibit reduced epidermal barrier function with enhanced susceptibility to environmental sensitization [31]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Kawasaki, 2012, Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice, J. Allergy Clin. Immunol. source
May combine two claims.
PremisecitationLOR expression is markedly decreased in the lesional skin of atopic dermatitis and is normalized after topical treatment.
“In parallel, the expression of LOR is markedly decreased in the lesional skin of atopic dermatitis and is normalized after topical treatment [13,34].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [13] Bergboer, 2013, Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis, J. Clin. Investig.
Not checked in the free run.
- cites [34] Chiricozzi, 2009, Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis, J. Allergy Clin. Immunol. source
May combine two claims.
PremisecitationAPE-containing cosmetic products improve desquamation, dryness, itching, and erythema in patients with atopic dermatitis.
“Skin care products containing Artemisia princeps extract (APE) are known to improve dry skin symptoms in atopic dermatitis.”
- Also stated in: § 1. Introduction · plain
“Moreover, APE-containing cosmetic products, such as body cream, skin lotion, and shampoo, improve desquamation, dryness, itching, and erythema in patients with atopic dermatitis [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Sasaki, 1995, Clinical evaluation of skin-care-products on atopic dermatitis, J. Pediatr. Dermatol.
Not checked in the free run.
- Also stated in: § 1. Introduction · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLoss-of-function mutation of the FLG gene is associated with the development of atopic dermatitis.
“loss-of-function mutation of the FLG gene is associated with the development of atopic dermatitis [10,11]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Palmer, 2006, Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis, Nat. Genet. source
- cites [11] Park, 2015, Novel FLG null mutations in Korean patients with atopic dermatitis and comparison of the mutational spectra in Asian populations, J. Dermatol. source
May combine two claims.
Study design and conductown dataNHEKs were constantly viable with APE ≤0.03%, and these concentrations were used throughout the experiments.
“As NHEKs were constantly viable with APE ≤ 0.03%, these concentrations were used throughout the experiments.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBarrier function is significantly disturbed in Ahr-null mice, indicating AHR plays a pivotal role in skin barrier integrity.
“In addition, barrier function is significantly disturbed in Ahr-null mice, indicating that AHR plays a pivotal role in skin barrier integrity [30].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Haas, 2016, Aryl hydrocarbon receptor in keratinocytes is essential for murine skin barrier integrity, J. Investig. Dermatol. source
The paper relies on this without support.
Upregulation of FLG and LOR gene expression by APE in cultured NHEKs is sufficient to produce barrier-repairing effects in atopic dry skin.
“In conclusion, antioxidant APE is a potent phytoextract that upregulates FLG and LOR expression in an AHR/OVOL1-dependent manner and this may underpin the barrier-repairing effects of APE in treating atopic dry skin.”
The paper relies on this without support.
The AHR/OVOL1 pathway operates similarly in cultured NHEKs and in atopic dry skin in vivo.
“Targeting AHR/OVOL1/FLG or LOR signaling may be a promising strategy to overcome atopic dry skin.”
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978 · see citing works
The skin: an indispensable barrier
Proksch, E., Brandner, J. M., & Jensen, J. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00786.x · Cited by 2,054 · see citing works
Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.
Smith, S. H., Jayawickreme, C., Rickard, D. J., Nicodeme, E., Bui, T., Simmons, C., Coquery, C. M., Neil, J., Pryor, W. M., Mayhew, D., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.004 · Cited by 387 · see citing works
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases
Kubo, A., Nagao, K., & Amagai, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57416 · Cited by 378 · see citing works
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
van den Bogaard, E. H., Bergboer, J. G. M., Vonk-Bergers, M., van Vlijmen-Willems, I. M. J. J., Hato, S. V., van der Valk, P. G. M., Schröder, J. M., Joosten, I., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65642 · Cited by 373 · see citing works
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis
Jensen, J.-M., Fölster-Holst, R., Baranowsky, A., Schunck, M., Winoto-Morbach, S., Neumann, C., Schütze, S., & Proksch, E. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22621.x · Cited by 309 · see citing works
Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Kawasaki, H., Nagao, K., Kubo, A., Hata, T., Shimizu, A., Mizuno, H., Yamada, T., & Amagai, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.068 · Cited by 301 · see citing works
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis
Guttman-Yassky, E., Suárez-Fariñas, M., Chiricozzi, A., Nograles, K. E., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Lin, P., Bergman, R., Bowcock, A. M., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.031 · Cited by 268 · see citing works
Egawa, G., & Kabashima, K. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.002 · Cited by 265 · see citing works
Elias, P. M., & Wakefield, J. S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.048 · Cited by 238 · see citing works
Functions of the aryl hydrocarbon receptor in the skin
Esser, C., Bargen, I., Weighardt, H., Haarmann-Stemmann, T., & Krutmann, J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0394-4 · Cited by 187 · see citing works
Role of AhR/ARNT system in skin homeostasis
Furue, M., Takahara, M., Nakahara, T., & Uchi, H. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1481-7 · Cited by 175 · see citing works
Self-citationTsuji, G., Takahara, M., Uchi, H., Matsuda, T., Chiba, T., Takeuchi, S., Yasukawa, F., Moroi, Y., & Furue, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.194 · Cited by 169 · see citing works
Self-citationAryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
Tsuji, G., Hashimoto-Hachiya, A., Kiyomatsu-Oda, M., Takemura, M., Ohno, F., Ito, T., Morino-Koga, S., Mitoma, C., Nakahara, T., Uchi, H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.322 · Cited by 149 · see citing works
Self-citationGene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor
Furue, M., Tsuji, G., Mitoma, C., Nakahara, T., Chiba, T., Morino-Koga, S., & Uchi, H. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.07.011 · Cited by 132 · see citing works
Self-citationAryl Hydrocarbon Receptor in Keratinocytes Is Essential for Murine Skin Barrier Integrity
Haas, K., Weighardt, H., Deenen, R., Köhrer, K., Clausen, B., Zahner, S., Boukamp, P., Bloch, W., Krutmann, J., & Esser, C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.627 · Cited by 125 · see citing works
Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., & Tsuji, G. (2017) · Nutrients · doi:10.3390/nu9030223 · Cited by 113 · see citing works
Self-citationKennedy, L. H., Sutter, C. H., Leon Carrion, S., Tran, Q. T., Bodreddigari, S., Kensicki, E., Mohney, R. P., & Sutter, T. R. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs325 · Cited by 100 · see citing works
Sutter, C. H., Bodreddigari, S., Campion, C., Wible, R. S., & Sutter, T. R. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr205 · Cited by 93 · see citing works
Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H. C., Webster, J., Ip, W., Tang, L., & Lyle, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10775.x · Cited by 92 · see citing works
Uchi, H., Yasumatsu, M., Morino-Koga, S., Mitoma, C., & Furue, M. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.10.003 · Cited by 82 · see citing works
Self-citationTakei, K., Mitoma, C., Hashimoto‐Hachiya, A., Uchi, H., Takahara, M., Tsuji, G., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12717 · Cited by 81 · see citing works
Self-citationAhR protein trafficking and function in the skin
Ikuta, T., Namiki, T., Fujii-Kuriyama, Y., & Kawajiri, K. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.003 · Cited by 68 · see citing works
Hou, M., Sun, R., Hupe, M., Kim, P. L., Park, K., Crumrine, D., Lin, T., Santiago, J. L., Mauro, T. M., Elias, P. M., et al. (2013) · Experimental Dermatology · doi:10.1111/exd.12102 · Cited by 66 · see citing works
Hou, M., Man, M., Man, W., Zhu, W., Hupe, M., Park, K., Crumrine, D., Elias, P. M., & Man, M. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01455.x · Cited by 62 · see citing works
Frauenstein, K., Sydlik, U., Tigges, J., Majora, M., Wiek, C., Hanenberg, H., Abel, J., Esser, C., Fritsche, E., Krutmann, J., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.102 · Cited by 56 · see citing works
Yamamoto, N., Kanemoto, Y., Ueda, M., Kawasaki, K., Fukuda, I., & Ashida, H. (2011) · Food Funct. · doi:10.1039/c0fo00129e · Cited by 52 · see citing works
Park, J., Jekarl, D. W., Kim, Y., Kim, J., Kim, M., & Park, Y. M. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12935 · Cited by 50 · see citing works
Nakahara, T., Mitoma, C., Hashimoto-Hachiya, A., Takahara, M., Tsuji, G., Uchi, H., Yan, X., Hachisuka, J., Chiba, T., Esaki, H., et al. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3396 · Cited by 49 · see citing works
Self-citationTakei, K., Mitoma, C., Hashimoto‐Hachiya, A., Takahara, M., Tsuji, G., Nakahara, T., & Furue, M. (2015) · Clinical and Experimental Dermatology · doi:10.1111/ced.12635 · Cited by 45 · see citing works
Self-citationEffect of Phenobarbital on Hepatic CYP1A1 and CYP1A2 in the Ahr-Null Mouse
Zaher, H., Yang, T. J., Gelboin, H. V., Fernández‐Salguero, P. M., & Gonzalez, F. J. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00476-0 · Cited by 40 · see citing works
Bader, A., Martini, F., Schinella, G. R., Rı́os, J. L., & Prieto, J. M. (2014) · Phytotherapy Research · doi:10.1002/ptr.5234 · Cited by 37 · see citing works
(2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2013.10.02 · Cited by 34 · see citing works
Doi, K., Mitoma, C., Nakahara, T., Uchi, H., Hashimoto‐Hachiya, A., Takahara, M., Tsuji, G., Nakahara, M., & Furue, M. (2014) · PubMed · doi:10.15017/1495227 · Cited by 19 · see citing works
Self-citationEunjeong, Choi, Gunhee, & Kim, K. (2013) · Cited by 17 · see citing works
Chung, K.-S., Choi, H.-E., Shin, J.-S., Cho, E.-J., Cho, Y.-W., Choi, J.-H., Baek, N.-I., & Lee, K.-T. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.11.007 · Cited by 14 · see citing works
Studies on Anti-inflammatory Effects of Mugwort Extracts.
Watanabe, M., Nakata, K., Monji, K., Nayeshiro, H., & Makino, T. (1994) · Journal of Society of Cosmetic Chemists of Japan · doi:10.5107/sccj.28.178 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Sasaki, 1995, Clinical evaluation of skin-care-products on atopic dermatitis, J. Pediatr. Dermatol., 14, 89
Cited by
Sorted by citations
Furue, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155382 · Cited by 419 · see citing works
Self-citationAryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Furue, M., Hashimoto-Hachiya, A., & Tsuji, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215424 · Cited by 215 · see citing works
Self-citationFurue, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113741 · Cited by 157 · see citing works
Self-citationHashimoto‐Hachiya, A., Tsuji, G., Murai, M., Yan, X., & Furue, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061654 · Cited by 58 · see citing works
Self-citationRecent advancements in the atopic dermatitis mechanism
Savva, M., Papadopoulos, N. G., Gregoriou, S., Katsarou, S., Papapostolou, N., Makris, M., & Xepapadaki, P. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2902084 · Cited by 53 · see citing works
Dębińska, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112506 · Cited by 52 · see citing works
Furue, M., Hashimoto‐Hachiya, A., & Tsuji, G. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-3003 · Cited by 43 · see citing works
Self-citationAryl Hydrocarbon Receptor and Dioxin-Related Health Hazards—Lessons from Yusho
Furue, M., Ishii, Y., Tsukimori, K., & Tsuji, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020708 · Cited by 39 · see citing works
Self-citationKim, K.-H., Shim, J. S., Kim, H.-J., & Son, E. D. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112337 · Cited by 31 · see citing works
Gu, Y., Wang, X., Liu, F., Zhang, J. C., Zhang, X., Liu, J., Li, S., Wang, D., Guan, H., & Hou, D. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115195 · Cited by 30 · see citing works
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Tsuji, G., Yamamura, K., Kawamura, K., Kido‐Nakahara, M., Ito, T., & Nakahara, T. (2023) · Biomedicines · doi:10.3390/biomedicines11051303 · Cited by 30 · see citing works
Self-citationKim, J. W., Choi, H. G., Song, J. H., Kang, K. S., & Shim, S. H. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0131-2 · Cited by 28 · see citing works
Yu, D., Huang, N., & Du, X. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230330152345 · Cited by 28 · see citing works
Song, M., Sheng, X., Zhang, J., Li, X., Dai, Q., Chen, Y., & An, K. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115545 · Cited by 27 · see citing works
Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis
Lee, J., Song, K., & Jung, C. H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153418 · Cited by 26 · see citing works
Oh, J. H., Karadeniz, F., Lee, J. I., Seo, Y., & Kong, C. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.3.299 · Cited by 26 · see citing works
Park, D. H., Kothari, D., Niu, K., Han, S. G., Yoon, J. E., Lee, H., & Kim, S. (2019) · Animals · doi:10.3390/ani9090690 · Cited by 23 · see citing works
Lee, E., Min, K., Ahn, H., Jeon, B., Park, S., Yun, C., Jeon, H., Yeon, J.-S., Kim, H., & Park, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179551 · Cited by 23 · see citing works
Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1
Tsuji, G., Hashimoto‐Hachiya, A., Vu, Y. H., Miake, S., Takemura, M., Mitamura, Y., Ito, T., Murata, M., Furue, M., & Nakahara, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030891 · Cited by 21 · see citing works
Self-citationGalactomyces Ferment Filtrate Potentiates an Anti-Inflammaging System in Keratinocytes
Yan, X., Tsuji, G., Hashimoto-Hachiya, A., & Furue, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216338 · Cited by 20 · see citing works
Self-citationSu, L., Ma, W., Ma, Y., Li, T.-Z., Geng, C., Dong, W., He, X.-F., & Chen, J. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113714 · Cited by 20 · see citing works
Furue, M., Uchi, H., Mitoma, C., Hashimoto‐Hachiya, A., Tanaka, Y., Ito, T., & Tsuji, G. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06132-1 · Cited by 19 · see citing works
Self-citationAryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review
Dec, M., & Arasiewicz, H. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.135617 · Cited by 18 · see citing works
Anti-allergic activity of natural plant products for the treatment of sensitive skin: A review
Guo, M., Xue, W.-T., Liao, L.-Y., Ling, X., Yu, D., Lan, X.-L., Zhou, W., & LiLi (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100117 · Cited by 16 · see citing works
Li, Y., Won, K., Kim, D. Y., Kim, H. B., Kang, H. M., Lee, S. Y., & Lee, H. M. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202001051 · Cited by 15 · see citing works
Ovol1/2 loss‐induced epidermal defects elicit skin immune activation and alter global metabolism
Dragan, M., Chen, Z., Li, Y., Le, J., Sun, P., Haensel, D., Sureshchandra, S., Pham, A., Lu, E., Pham, K. T., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256214 · Cited by 12 · see citing works
T helper type 2 signatures in atopic dermatitis
Furue, M. (2018) · Journal of Cutaneous Immunology and Allergy · doi:10.1002/cia2.12023 · Cited by 14 · see citing works
Self-citationPromising strategies in natural products treatments of psoriasis-update
Le, S., Wu, X. R., Dou, Y., Song, T., Fu, H., Luo, H., Zhang, F., & Cao, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1386783 · Cited by 13 · see citing works
Revival of AHR Agonist for the Treatment of Atopic Dermatitis: Tapinarof
Furue, M., & Nakahara, T. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00259-7 · Cited by 12 · see citing works
Self-citationLiu, R., Choi, H. S., Ko, Y.-C., Yun, B., & Lee, D. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119729 · Cited by 11 · see citing works
Xie, W.-Y., Shen, H., Yan, Z.-M., Zheng, R.-J., Jiang, J., Zhong, J., & Zhou, W.-W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135404 · Cited by 8 · see citing works
Kim, J.-H., An, C.-H., Hwang, S. D., & Kim, Y. (2021) · Cosmetics · doi:10.3390/cosmetics8040101 · Cited by 5 · see citing works
Atopic Dermatitis and Type 2 Immune Deviation
Furue, M., Ulzii, D., Vu, Y. H., Tsuji, G., Kido‐Nakahara, M., & Nakahara, T. (2019) · Current Treatment Options in Allergy · doi:10.1007/s40521-019-00219-w · Cited by 9 · see citing works
Self-citationLee, J., Choi, H., Shin, H. S., & Kim, G.-D. (2024) · Molecules · doi:10.3390/molecules29245951 · Cited by 7 · see citing works
Chemical Constituents of the Endophyte Penicillium sp. Isolated from Artemisia princeps
Jeon, H.-G., & Shim, S. H. (2020) · Chemistry of Natural Compounds · doi:10.1007/s10600-020-02959-7 · Cited by 7 · see citing works
Lee, W., Jeong, Y., Park, J.-H., Lee, C. H., Yun, N., Lee, D. S., Nam, I.-J., Kim, J.-D., Yoon, K. D., Son, M., et al. (2019) · Nutrients · doi:10.3390/nu11061366 · Cited by 7 · see citing works
Karadeniz, F., Oh, J. H., Jo, H. J., Yang, J., Lee, H., Seo, Y., & Kong, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020653 · Cited by 6 · see citing works
Igori, D., Lim, S., Cho, H. S., Kim, H., Park, J. M., Lee, H., Hong, K., Kwon, S., & Moon, J. S. (2021) · Archives of Virology · doi:10.1007/s00705-021-05004-2 · Cited by 6 · see citing works
Tan, Q., Li, H., Xia, L., Yang, J., Feng, G., Zhou, B., & Zhou, D. (2025) · Poultry Science · doi:10.1016/j.psj.2025.106170 · Cited by 3 · see citing works
Kim, N. Y., Won, K., Kim, D. Y., Lee, D. K., Kim, Y. Y., & Lee, H. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24434 · Cited by 3 · see citing works
Hu, Y., Liu, P., Mu, Z., & Zhang, J.-Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1699070/v1 · Cited by 2 · see citing works
Heinemann, N., Rademacher, F., Vollert, H., Gläser, R., & Harder, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-50000-8 · Cited by 1 · see citing works
Eupatilin: Sources, Extraction, Derivatives, and Pharmacological Activity
Malhotra, H., Ashri, A., Singla, R. K., & Gautam, R. K. (2023) · Springer eBooks · doi:10.1007/978-3-030-94753-8_84-1 · Cited by 1 · see citing works
Gu, Y., Wang, X., Liu, F., Jin, Z., Zhang, X., Liu, J., Li, S., Wang, D., Guan, H., & Hou, D. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4000526 · Cited by 1 · see citing works
Vedhika, M., Godatwar, P., Reetu, S., Kumar, P. N., Jamas, J. P., & Kalpana, D. (2023) · International Journal of Ayurveda and Pharma Research · doi:10.47070/ijapr.v11i4.2728
Yaralı, O., & Güler, T. (2026) · New Trends in Medicine Sciences · doi:10.56766/ntms.1744180
Evaluation of the skin-improving effects of Artemisia fukudo Makino extract
Kim, E. H., Park, M. Y., Lee, H. Y., Kim, J. H., Oh, G. Y., Lee, S. H., Ha, T.-M., Kim, J.-Y., Na, H. S., Park, S., et al. (2026) · Food Science and Preservation · doi:10.11002/fsp.2026.33.3.543
Hazlianda, C. P., Pane, Y. S., Lubis, R. D. S., Rambe, A. Y. M., Djawad, K., Laksmi, L. I., Amin, M. M., & Restimulia, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1883375
- Authors
- Hirano, A., Goto, M., Mitsui, T., Hashimoto-Hachiya, A., Tsuji, G., & Furue, M.
- Affiliations
- Sunstar (Japan) (JP)
- Department of Dermatology, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan
- Kyushu University (JP)
- Corresponding author
- Hirano, Akiko
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-09-11
- Volume
- 18
- Issue
- 9
- Pages
- 1948
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618597
- OpenAlex
- W2756224750
- Cited by
- 48
- References
- 38
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 6 · 2019: 7 · 2018: 4
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- Artemisia princeps, aryl hydrocarbon receptor, OVOL1, filaggrin, loricrin, skin barrier proteins, keratinocytes, heme oxygenase-1, NQO1, CYP1A1, gene expression regulation
- MeSH terms
- Filaggrin Proteins, Antioxidants, Cell Line, DNA-Binding Proteins, Humans, Intermediate Filament Proteins, Membrane Proteins, NADPH Dehydrogenase, Plant Extracts, Transcription Factors, Keratinocytes, Receptors, Aryl Hydrocarbon, Artemisia, Cytochrome P-450 CYP1A1, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-31.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-31.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review